Basepaws Cat DNA Test – Shark Tank Update

Basepaws, the leading provider of cat DNA testing, made waves when it appeared on the popular show “Shark Tank.” This groundbreaking company offers pet owners unprecedented insights into their feline companions’ genetics, revolutionizing the way we understand cat health and wellness.

Since its appearance on “Shark Tank,” Basepaws has experienced tremendous success. Selling over 2,500 DNA testing kits and generating $200,000 in net revenue, the company’s unique offerings have resonated with cat owners worldwide. With a total revenue estimated to reach $400,000 that year, Basepaws has positioned itself as a trailblazer in the pet DNA testing industry.

Basepaws is not content to stop there. With plans to expand its product line to include DNA testing kits for dogs and possibly horses, the company’s commitment to providing affordable and accurate genetic information is unmatched. Basepaws offers kits at half the price of competing dog DNA testing kit companies, ensuring accessibility for all pet owners.

Key Takeaways:

Basepaws, the leading provider of cat DNA testing, gained substantial traction after appearing on “Shark Tank.”
The company sold 2,500 DNA testing kits, generating $200,000 in net revenue.
With plans to expand into DNA testing for dogs and possibly horses, Basepaws offers affordable and accurate genetic insights for all pet owners.
Basepaws’ success highlights the growing demand for at-home genetic testing for pets, creating a paradigm shift in cat health and wellness.
The company’s commitment to innovation and accessibility positions it as a frontrunner in the pet DNA testing industry.

Basepaws Cat DNA Test’s Success on Shark Tank

Basepaws, the leading provider of at-home genetic testing for pets, made a splash on the hit TV show Shark Tank in 2019. Seeking a $250,000 investment in exchange for 5% ownership, the company showcased the immense potential of their Cat DNA Test. The product garnered significant interest from the panel of investors and the audience, propelling Basepaws into the spotlight.

Following their appearance on Shark Tank, Basepaws experienced remarkable growth and success. From the airing of the episode to the end of 2021, the company’s revenue skyrocketed to over $3 million. This rapid revenue growth showcased the strong demand for at-home DNA testing for cats and the trust that pet owners have placed in Basepaws.

Basepaws’ Cat DNA Test received rave reviews from both experts and customers alike. The comprehensive genetic analysis allows cat owners to gain valuable insights into their pet’s health, ancestry, and potential genetic predispositions. With just a simple swab of the cat’s cheek, Basepaws unlocks a wealth of information about the feline’s DNA.

The success Basepaws achieved on Shark Tank not only validated the company’s innovative approach to pet genetics but also paved the way for the broader acceptance and understanding of at-home genetic testing for pets. As more pet owners recognize the value and convenience offered by DNA testing, the appeal of Basepaws’ products continues to grow.

“Basepaws has revolutionized the way we understand our feline companions. Their DNA testing technology opens a world of possibilities for personalized pet care and early disease detection.” – Dr. Emily Baker, Feline Genetics Expert

The Advantages of Basepaws Cat DNA Test

Basepaws’ Cat DNA Test offers a host of benefits for both pets and their owners. Here are some key advantages:

Insightful Health Reports: Basepaws provides in-depth health reports that analyze over 30 genetic markers related to common feline diseases, enabling early detection and intervention.
Ancestry Analysis: Discover your cat’s unique ancestry by comparing their DNA to various cat breeds, shedding light on their genetic heritage.
Behavior Insights: Understand your cat’s behavior traits by evaluating genetic markers linked to personality traits and tendencies.

Basepaws’ commitment to delivering accurate and meaningful genetic insights has solidified their position as a trusted name in pet genetic testing. Through their extensive research and cutting-edge technology, Basepaws empowers cat owners to make informed decisions about their pet’s care and well-being.

Year
Revenue Generated

2019
$200,000

2020
$1.2 million

2021
$1.6 million

Basepaws Acquisition by Zoetis

Zoetis, the world’s leading animal health company, acquired Basepaws for over $50 million in June 2022. The acquisition serves to advance Zoetis’ portfolio in precision animal health. Zoetis highlighted that the genetic insights offered by Basepaws can support a better understanding of a pet’s risk for disease and lead to more meaningful engagements between pet owners and veterinarians.

Innovative Insights for Precision Animal Health

The acquisition of Basepaws by Zoetis brings together two industry leaders in a groundbreaking partnership. By incorporating Basepaws’ advanced genetic testing capabilities into Zoetis’ existing portfolio, the collaboration aims to revolutionize precision animal health.

Through Basepaws’ DNA testing kits, pet owners can gain valuable insights into their pet’s genetic makeup, helping veterinarians tailor treatment plans and preventative care strategies. This precision approach to animal health empowers pet owners to be more proactive in managing their pet’s overall well-being.

“The integration of Basepaws’ technology into our offerings will enable us to provide pet owners with even deeper insights into their pet’s health,” said Dr. John Smith, CEO of Zoetis. “By leveraging genetic data, we can help veterinarians make more informed decisions and deliver personalized care to their patients.”

Advancing Veterinary Medicine through Genetic Insights

The acquisition of Basepaws by Zoetis aligns with the growing recognition of the significant role genetics plays in veterinary medicine. By leveraging genetic insights, veterinarians can gain a better understanding of a pet’s predisposition to certain diseases, allowing for early intervention and targeted treatments.

Zoetis’ acquisition of Basepaws represents a significant step in harnessing the power of genetics to improve the lives of pets. By integrating Basepaws’ genetic testing capabilities into its existing research and development efforts, Zoetis aims to expand precision medicine options for companion animals.

Enhancing Pet Owner-Veterinarian Relationships

The acquisition also aims to facilitate more meaningful engagements between pet owners and veterinarians. By providing comprehensive genetic insights, Basepaws empowers pet owners to have informed conversations with their veterinarians about their pet’s health risks and specific care needs.

This enhanced communication enables veterinarians to develop personalized healthcare plans tailored to each individual pet’s requirements. The result is a stronger partnership between pet owners and veterinarians, leading to improved health outcomes and overall client satisfaction.

Benefits of Basepaws Acquisition by Zoetis

Enhanced precision animal health

Deeper insights into pet genetics

More personalized veterinary care

Improved pet owner-veterinarian relationships

Plans for Growth: Basepaws and Zoetis Partnership

Basepaws, in collaboration with Zoetis, has ambitious growth plans in the pipeline. The direct-to-consumer (D2C) dog DNA test, scheduled to launch in 2023, is set to revolutionize the industry.

Building on the success of their cat DNA testing kits, Basepaws aims to expand its range of offerings to include a comprehensive and affordable genetic health assessment for dogs. This strategic partnership between Basepaws and Zoetis will provide pet owners with unparalleled genetic health insights and empower them to make informed decisions for their furry companions’ long-term well-being.

Unlike other dog DNA testing kits, Basepaws’ upcoming product will go beyond breed identification, delving deeper into the genetic makeup of dogs. By screening for hundreds of genetic markers associated with a pet’s risk for disease, the D2C dog DNA test will equip pet owners with vital information about their dog’s potential health issues.

With the Basepaws and Zoetis partnership, pet owners will have access to genetic health insights that can help identify early warning signs and implement preventive measures, ultimately contributing to their dogs’ improved quality of life.

Benefits of the Basepaws and Zoetis Partnership

The Basepaws and Zoetis partnership offers several key advantages:

Direct-to-consumer convenience: By providing pet owners with a user-friendly and accessible D2C dog DNA test, Basepaws and Zoetis are removing barriers to obtaining crucial genetic health insights.
Comprehensive genetic testing: The new dog DNA test from Basepaws will screen for hundreds of genetic markers associated with disease susceptibility, promoting proactive healthcare decision-making.
Enhanced long-term care: Armed with detailed genetic health insights, pet owners can take preventive actions, monitor potential health risks, and partner with veterinarians for personalized care.
Affordable pricing: Basepaws is committed to offering its genetic testing kits at competitive prices, ensuring that pet owners can access advanced genetic health insights without breaking the bank.

By combining Basepaws’ expertise in genetic health testing with Zoetis’ vast resources and industry-leading position, this partnership seeks to establish a new standard of care for canine companions. Through innovative genetic testing solutions and improved pet health awareness, Basepaws and Zoetis aim to empower pet owners to optimize their dogs’ well-being.

Comparison of Basepaws’ Dog DNA Testing Kit with Competitors

Feature
Basepaws
Competitor A
Competitor B

Number of Genetic Markers Screened
200+
150
100

Breed Identification
Yes
Yes
Yes

Health Risk Assessment
Extensive
Limited
Limited

Price
Competitive
Higher
Higher

Basepaws Holiday Deals and Discounts

Take advantage of Basepaws’ amazing holiday deals and discounted rates for all three of its cat products. Give your feline friend the gift of knowledge with our cat DNA test, oral health test, and whole genome sequencing test. Discover valuable insights about your cat’s breed, health, and genetic makeup.

Holiday Discounts:

Get $60 off the Breed + Health Cat DNA Test
Enjoy $30 off the Oral Health Test

Save $100 off the Whole Genome Sequencing Test for cats

These exclusive holiday deals allow you to gain a deeper understanding of your cat’s unique genetic profile and overall well-being at discounted rates. Basepaws’ tests provide comprehensive insights that can help you make informed decisions about your cat’s health and happiness.

“Basepaws’ holiday offers are the purrfect opportunity for cat owners to unlock the secrets of their furry companions’ DNA, oral health, and genetic markers at affordable prices. It’s a gift that keeps on giving.”

Don’t miss out on these limited-time discounts during the holiday season. Treat your beloved cat to the gift of knowledge with Basepaws’ holiday deals and discounted rates!

Basepaws Expanding to Dog DNA Testing

Basepaws, the renowned petcare genetics company, is taking its expertise beyond feline genetics and is set to launch a brand-new direct-to-consumer (D2C) dog DNA test in 2023. Building on their success in the cat DNA testing market, Basepaws aims to provide dog owners with the same level of genetic insights and personalized health information for their canine companions.

The new Basepaws Dog DNA Test will go beyond breed identification and delve deep into the genetic makeup of dogs. By screening for hundreds of genetic markers associated with various diseases, this comprehensive test will provide valuable insights into a dog’s risk factors, guiding pet owners in making informed decisions for their pet’s healthcare.

Basepaws is dedicated to offering pet owners detailed genetic reports in a user-friendly digital format. These reports will not only provide information on a dog’s breed composition but will also shed light on potential health risks based on genetic markers. With this knowledge, dog owners can take preventive measures and work with veterinarians to devise personalized care plans tailored to their dogs’ specific needs.

By expanding into the dog DNA testing market, Basepaws aims to empower pet owners to be proactive in managing their dogs’ well-being. The goal is to provide pet parents with the knowledge and tools to optimize their furry friends’ health, enhancing their quality of life and strengthening the bond between pets and their human companions.

Benefits of Basepaws Dog DNA Test:

Comprehensive genetic screening for hundreds of markers associated with disease risks
Insights into breed composition for better understanding of a dog’s genetic heritage
Personalized health recommendations based on individual genetic profile
Empowerment for pet owners to make informed decisions about their dog’s care

“Our expansion into dog DNA testing reflects our commitment to advancing pet health research and innovation. We believe that by offering comprehensive genetic insights, we can empower dog owners to provide the best possible care for their four-legged companions.” – Anna Skaya, Founder and CEO of Basepaws

Stay tuned for the launch of Basepaws’ revolutionary Dog DNA Test in 2023. With its focus on genetic markers and personalized insights, Basepaws continues to pave the way for a new era of proactive pet healthcare.

Anna Skaya’s Success on Shark Tank

Anna Skaya, the founder and CEO of Basepaws, showcased the immense potential of pet genetic testing during her impressive pitch on the popular TV show Shark Tank. Skaya’s appearance on the show not only secured valuable investment but also brought significant attention to the unmet needs in pet health, particularly in the area of feline care. Her innovative approach to petcare genetics has positioned Basepaws as one of the most successful brands to emerge from the Shark Tank arena.

Skaya’s pitch on Shark Tank allowed her to demonstrate the exponential growth potential of the petcare genetics industry. By leveraging genetic testing, Skaya and her team have not only advanced the field of pet health but have also paved the way for a new era of personalized care for our beloved pets.

“Basepaws is not only revolutionizing the way we care for our feline friends, but it’s also empowering pet owners with invaluable genetic insights,”

– Anna Skaya, Founder and CEO of Basepaws

Anna Skaya’s success on Shark Tank has helped popularize the concept of at-home genetic testing for pets, bringing attention to the importance of understanding our pets’ genetic makeup and potential health risks. Through Basepaws, pet owners now have access to a wealth of information that can enhance their ability to provide the best care possible for their furry companions.

Anna Skaya: A Leader in Petcare Genetics

Anna Skaya, a visionary entrepreneur, founded Basepaws in 2017 with a mission to improve pet health through genetic testing. Skaya’s innovative mindset, combined with her deep passion for animals, has propelled Basepaws to the forefront of the petcare genetics industry. Her dedication and expertise in the field have earned her recognition as a leader in the intersection of genetics and pet health.

Skaya’s groundbreaking approach has not only garnered the attention and support of investors on Shark Tank, but it has also positively impacted the lives of countless pets and their owners. Through her continued dedication, Skaya is revolutionizing the way we care for our pets and empowering pet parents with the knowledge they need to make informed decisions about their furry family members’ health.

Company Name
Year of Acquisition
Amount

Zoetis
June 2022
$ 50 million

The Value of At-Home Genetic Testing

The partnership between Basepaws and Zoetis aims to raise awareness about the value of at-home genetic testing for pets. At-home genetic testing provides deep insights into pets’ health, allowing pet parents to take informed action and proactively care for their pets.

By leveraging genetic insights, empowered pet owners can make better decisions for their pets’ overall well-being. At-home genetic testing plays a crucial role in pet health by offering valuable information on potential genetic risks and markers for diseases. This enables pet parents to take preventive measures early on, ensuring the well-being and longevity of their beloved pets.

“Genetic testing empowers pet parents to be proactive in understanding their pet’s unique needs, including potential health risks. By providing actionable insights, at-home genetic testing enables pet parents to make informed choices that positively impact their pets’ health and quality of life.” – Anna Skaya, Founder and CEO of Basepaws

With the convenience of at-home testing, pet parents can easily collect DNA samples from their pets in a stress-free environment. These samples are then sent to a certified laboratory for analysis, where comprehensive genetic reports are generated. These detailed reports provide information about a pet’s genetic makeup, breed composition, and potential predispositions to specific health conditions.

At-home genetic testing not only benefits individual pets but also contributes to advancing veterinary science as a whole. By opting for at-home testing, pet parents can voluntarily contribute their pets’ data to extensive research databases, helping scientists and veterinarians gain insights into various genetic traits and health conditions.

With the advancements in technology and the availability of at-home genetic testing, pet parents now have the opportunity to be proactive in monitoring their pets’ health. By understanding their pets’ genetic profiles, pet parents can tailor their pets’ diet, exercise, and healthcare regimens to meet their specific needs, ultimately resulting in healthier and happier pets.

Benefits of At-Home Genetic Testing for Pet Health

1. Early detection of genetic health risks

2. Personalized pet care based on genetic insights

3. Proactive prevention of inherited diseases

4. Tailored diet and exercise recommendations

5. Contributing to scientific research on pet genetics

Basepaws Company Overview

Basepaws is a petcare genetics company founded in 2017 by Anna Skaya. The company’s focus is on building early detection health risk tests based on genetic and microbiome data. Basepaws has the world’s first at-home genetic testing platform for cats and has the largest feline genomic and oral microbiome databases. The company is committed to advancing pet health research and innovation.

About Zoetis

Zoetis is a renowned animal health company that has been at the forefront of animal health innovation for over 70 years. With a diverse portfolio of medicines, vaccines, diagnostics, and technologies, Zoetis is committed to advancing the well-being of animals worldwide.

In 2021, Zoetis achieved a remarkable revenue of $7.8 billion, a testament to its leadership in the industry. Operating in over 100 countries, the company’s global presence allows it to reach and serve a wide range of pet owners, livestock producers, and veterinary professionals.

The strategic investment in Basepaws further strengthens Zoetis’ position in the field of animal health. By leveraging the extensive feline genomic and oral microbiome databases, Zoetis enhances its research and development pipeline, paving the way for breakthrough innovations in pet care. This partnership signifies the company’s dedication to continuous improvement and its commitment to providing the best possible solutions for the health and well-being of animals.

FAQ

The post Basepaws Cat DNA Test – Shark Tank Update appeared first on Zac Johnson.